Marijuana's Move to Schedule III

In this week's of GameChangers Podcast, we delve into the groundbreaking reclassification of marijuana to Schedule III. We discuss  impacts on the legal landscape, medical research, pharmacogenomics for CBD, and the role of healthcare providers.  The GameChangerMarijuana's move to Schedule III will increase research opportunities, ease fear and stigma, and provide healthcare provider involvement in medical benefits and potential risks. HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health GuestMarry Vuong, PharmD, BCPPS Clinical Pharmacy ManagerPerfecting PedsReferenceUPDATE: DEA Moves to Reschedule Cannabis from Cannabis Business TimesNPR: Scientists welcome new rules on marijuana, but research will still face obstacles. CEimpact Course for Reference:Beyond the Haze: Pharmacist's Legal Insights on THC, CBD, and Medical MarijuanaPharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the reclassification of marijuana from Schedule I to Schedule III.2. Explain the potential benefits of the marijuana schedule change including its impact on medical research and patient access.0.05 CEU/0.5 HrUAN: 0107-0000-24-180-H01-PInitial release date: 05/27/2024Expiration date: 05/27/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram